Marathon Asset Management Ltd - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
Marathon Asset Management Ltd ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$20,784,708
-15.8%
765,833
-4.6%
0.64%
-6.9%
Q2 2023$24,688,730
-23.3%
803,167
-10.1%
0.69%
-22.9%
Q1 2023$32,181,363
-21.0%
893,192
-13.4%
0.90%
-18.1%
Q4 2022$40,754,574
-5.5%
1,031,269
-4.0%
1.10%
-14.6%
Q3 2022$43,143,000
-47.8%
1,073,745
-45.4%
1.28%
-6.8%
Q2 2022$82,623,000
+2.1%
1,965,336
-5.4%
1.38%
+25.6%
Q1 2022$80,908,000
-9.5%
2,076,728
-7.4%
1.10%
-0.8%
Q4 2021$89,357,0002,242,3301.11%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders